investor presentation
play

Investor Presentation November 2018 IMPORTANT INFORMATION This - PowerPoint PPT Presentation

Mar 24, 2023 •303 likes •686 views

Hybrid Capital Investor Presentation November 2018 IMPORTANT INFORMATION This investor presentation (this Presentation ") has been produced by DLF Seeds A/S (the Issuer ) and its subsidiaries (together the Group ) solely

  1. Hybrid Capital Investor Presentation November 2018

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

2014 Investor Day DECEMBER 10, 2014 5 | 2014 INVESTOR DAY | 2014 INVESTOR DAY Welcome MARK

2014 Investor Day DECEMBER 10, 2014 5 | 2014 INVESTOR DAY | 2014 INVESTOR DAY Welcome MARK

2014 Investor Day DECEMBER 10, 2014 5 | 2014 INVESTOR DAY | 2014 INVESTOR DAY Welcome MARK HADEN, INVESTOR RELATIONS 1 | 2014 INVESTOR DAY | 2014 INVESTOR DAY Wi-Fi Access in the Mandarin Oriental Ballroom SSID: MandarinOriental-NYC

1.71k views • 104 slides
INTUIT INVESTOR DAY September 17, 2015 INTUIT INVESTOR DAY Matt Rhodes VP, Investor Relations

INTUIT INVESTOR DAY September 17, 2015 INTUIT INVESTOR DAY Matt Rhodes VP, Investor Relations

INTUIT INVESTOR DAY September 17, 2015 INTUIT INVESTOR DAY Matt Rhodes VP, Investor Relations and Corporate FP&A Investor Day Agenda CEO Perspective Brad Smith Win Worldwide With QBO Ecosystem Dan Wernikoff Win With Accountants Who

2.43k views • 156 slides
INVESTOR PRESENTATION INVESTOR PRESENTATION INVESTOR PRESENTATION INVESTOR PRESENTATION June ,

INVESTOR PRESENTATION INVESTOR PRESENTATION INVESTOR PRESENTATION INVESTOR PRESENTATION June ,

INVESTOR PRESENTATION INVESTOR PRESENTATION INVESTOR PRESENTATION INVESTOR PRESENTATION June , 2013 Confidential I MPORTANT MPORTANT N N OTICE OTICE Safe Harbor This presentation contains statements that contain forward looking

892 views • 24 slides
A low r is k cop p e r p rod u cer in E u rop e Investor Pres esentation Investor

A low r is k cop p e r p rod u cer in E u rop e Investor Pres esentation Investor

A low r is k cop p e r p rod u cer in E u rop e Investor Pres esentation Investor Presentation February 2018 Dec December 20 2017 17 AIM:ATYM / TSX:AYM Disclaimer The information contained in this confidential document

520 views • 31 slides
Investor Presentation January 2019 DISCLAIMER This investor presentation (Investor

Investor Presentation January 2019 DISCLAIMER This investor presentation (Investor

Investor Presentation January 2019 DISCLAIMER This investor presentation (Investor Presentation) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase

415 views • 38 slides
2018 Investor Conference 2018 Investor Conference Rebekah Manis Director of Investor Relations

2018 Investor Conference 2018 Investor Conference Rebekah Manis Director of Investor Relations

2018 Investor Conference 2018 Investor Conference Rebekah Manis Director of Investor Relations VISION AND PURPOSE RODNEY MCMULLEN CREATE SHAREHOLDER VALUE MIKE SCHLOTMAN REDEFINE GROCERY CX MIKE DONNELLY DIGITAL EXPERIENCE YAEL COSSET

1.7k views • 106 slides
Investor Presentation Investor Presentation Investor Presentation Investor Presentation June

Investor Presentation Investor Presentation Investor Presentation Investor Presentation June

Investor Presentation Investor Presentation Investor Presentation Investor Presentation June June 2016 2016 Forward-Looking Statements Statements we make in this presentation that express a belief, expectation, or intention are forward

768 views • 34 slides
Euromoney Institutional Investor PLC Euromoney Institutional Investor PLC www.euromoneyplc.com

Euromoney Institutional Investor PLC Euromoney Institutional Investor PLC www.euromoneyplc.com

Annual Report & Accounts 2014 Euromoney Institutional Investor PLC Euromoney Institutional Investor PLC www.euromoneyplc.com Euromoney Institutional Investor PLC is listed on the London Stock Exchange and a member of the FTSE 250 share

2.05k views • 150 slides
Investor Presentation January 2019 DISCLAIMER This investor presentation (Investor

Investor Presentation January 2019 DISCLAIMER This investor presentation (Investor

Investor Presentation January 2019 DISCLAIMER This investor presentation (Investor Presentation) is for informational purposes only and does not constitute an offer to s ell, a solicitation of an offer to buy, or a recommendation to purchase

985 views • 23 slides
IPG Investor Presentation IPG Investor Presentation August 2018 IPG Investor Presentation 2

IPG Investor Presentation IPG Investor Presentation August 2018 IPG Investor Presentation 2

IPG Investor Presentation IPG Investor Presentation August 2018 IPG Investor Presentation 2 Safe Harbor Statement Certain statements and information included in this presentation constitute "forward-looking information" within

437 views • 23 slides
IPG Investor Presentation IPG Investor Presentation December 2017 IPG Investor Presentation 2

IPG Investor Presentation IPG Investor Presentation December 2017 IPG Investor Presentation 2

IPG Investor Presentation IPG Investor Presentation December 2017 IPG Investor Presentation 2 Safe Harbor Statement Certain statements and information included in this presentation constitute "forward-looking information" within the

556 views • 22 slides
IPG Investor Presentation IPG Investor Presentation September 2015 IPG Investor Presentation 2

IPG Investor Presentation IPG Investor Presentation September 2015 IPG Investor Presentation 2

IPG Investor Presentation IPG Investor Presentation September 2015 IPG Investor Presentation 2 Safe Harbor Statement Certain statements and information included in this presentation constitute "forward-looking information" within

845 views • 25 slides
IPG Investor Presentation IPG Investor Presentation November 2016 IPG Investor Presentation 2

IPG Investor Presentation IPG Investor Presentation November 2016 IPG Investor Presentation 2

IPG Investor Presentation IPG Investor Presentation November 2016 IPG Investor Presentation 2 Safe Harbor Statement Certain statements and information included in this presentation constitute "forward-looking information" within the

681 views • 23 slides
IPG Investor Presentation IPG Investor Presentation August 2017 IPG Investor Presentation 2

IPG Investor Presentation IPG Investor Presentation August 2017 IPG Investor Presentation 2

IPG Investor Presentation IPG Investor Presentation August 2017 IPG Investor Presentation 2 Safe Harbor Statement Certain statements and information included in this presentation constitute "forward-looking information" within the

614 views • 22 slides
INVESTOR PRESENTATION Investor Presentation August, 2013 Investor Presentation DISCLAIMER

INVESTOR PRESENTATION Investor Presentation August, 2013 Investor Presentation DISCLAIMER

1 INVESTOR PRESENTATION Investor Presentation August, 2013 Investor Presentation DISCLAIMER DISCLAIMER This presentation is for information purpose only and does not constitute an offer, solicitation or advertisement with respect to

748 views • 50 slides
Euromoney Institutional Investor PLC Euromoney Institutional Investor PLC www.euromoneyplc.com

Euromoney Institutional Investor PLC Euromoney Institutional Investor PLC www.euromoneyplc.com

Annual Report & Accounts 2013 Euromoney Institutional Investor PLC Euromoney Institutional Investor PLC www.euromoneyplc.com Euromoney Institutional Investor PLC is listed on the London Stock Exchange and is a member of the FTSE 250

2.24k views • 168 slides
The regulation of IVD medical devices Euan Miller Assistant Director, Devices Application and

The regulation of IVD medical devices Euan Miller Assistant Director, Devices Application and

The regulation of IVD medical devices Euan Miller Assistant Director, Devices Application and Verification Devices Authorisation Branch Market Authorisation Division, TGA ARCS Scientific Congress 2015 7 May 2015 Outline Overview of

821 views • 25 slides
Analysis of T-20 resistance HIV-genome http://www.hiv.lanl.gov/content/hiv-db/MAP/landmark.html

Analysis of T-20 resistance HIV-genome http://www.hiv.lanl.gov/content/hiv-db/MAP/landmark.html

M. Obermeier 4/2007 Analysis of T-20 resistance HIV-genome http://www.hiv.lanl.gov/content/hiv-db/MAP/landmark.html M. Obermeier 4/2007 M. Obermeier 4/2007 Struktur gp41 T-20 loop C-terminal heptad repeat (HR2) N-terminal heptad repeat

516 views • 14 slides
Aptose Corporate Presentation NASDAQ: APTO July 2020 TSX: APS www.aptose.com This presentation

Aptose Corporate Presentation NASDAQ: APTO July 2020 TSX: APS www.aptose.com This presentation

Aptose Corporate Presentation NASDAQ: APTO July 2020 TSX: APS www.aptose.com This presentation does not, and is not intended to, constitute or form part of, and should not be construed as, an offer or invitation for the sale or purchase of, or

497 views • 33 slides
Land Bank 101: The Basics of Land Banking in Ohio Lucas County Land Bank David Mann, President

Land Bank 101: The Basics of Land Banking in Ohio Lucas County Land Bank David Mann, President

Land Bank 101: The Basics of Land Banking in Ohio Lucas County Land Bank David Mann, President Joshua Murnen, Vice President & General Counsel 2016 Ohio Land Bank Conference Introductions & Your Questions Land Bank 101 Getting

1.15k views • 86 slides
GWAMAR: Genome-wide assessment of mutations associated with drug resistance in bacteria Michal

GWAMAR: Genome-wide assessment of mutations associated with drug resistance in bacteria Michal

Introduction Methods Results Summary GWAMAR: Genome-wide assessment of mutations associated with drug resistance in bacteria Michal Wozniak 1,2 , Limsoon Wong 2 and Jerzy Tiuryn 1 1 University of Warsaw 2 National University of Singapore 27

302 views • 26 slides
Malignant Melanoma Eric Klein, M.D. SUNY Downstate Department of Surgery

Malignant Melanoma Eric Klein, M.D. SUNY Downstate Department of Surgery

www.downstatesurgery.org Malignant Melanoma Eric Klein, M.D. SUNY Downstate Department of Surgery www.downstatesurgery.org Case Presentation www.downstatesurgery.org HPI 62 y/o male Vietnam veteran PMH HTN, hyperlipidemia,

544 views • 29 slides
The Artificially Intelligent Pharma & Healthcare Sector M. Morris Hosseini, MSc, PhD

The Artificially Intelligent Pharma & Healthcare Sector M. Morris Hosseini, MSc, PhD

The Artificially Intelligent Pharma & Healthcare Sector M. Morris Hosseini, MSc, PhD Senior Partner CC Pharma & Healthcare Roland Berger Grand Hyatt Athens, September 24 th 2018 What are the therapies of the future in the digital

540 views • 21 slides
Artificial Intelligence in Healthcare The Cleveland Clinic Way Aziz Nazha, MD Director,

Artificial Intelligence in Healthcare The Cleveland Clinic Way Aziz Nazha, MD Director,

Artificial Intelligence in Healthcare The Cleveland Clinic Way Aziz Nazha, MD Director, Center for Clinical Artificial Intelligence Associate Medical Director, Enterprise Analytics Assistant Professor of Medicine Lerner College of

468 views • 30 slides

More recommend